Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics

Sarepta Therapeutics, Inc. (SRPT)

Today's Latest Price: $98.04 USD

0.14 (0.14%)

Updated Nov 19 12:00am

Add SRPT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 328 in Biotech

See all "A" rated Strong Buy stocks

SRPT Stock Summary

  • With a price/sales ratio of 19.59, Sarepta Therapeutics Inc has a higher such ratio than 94.55% of stocks in our set.
  • Over the past twelve months, SRPT has reported earnings growth of 175.18%, putting it ahead of 92.92% of US stocks in our set.
  • As for revenue growth, note that SRPT's revenue has grown 42.76% over the past 12 months; that beats the revenue growth of 87.7% of US companies in our set.
  • Stocks that are quantitatively similar to SRPT, based on their financial statements, market capitalization, and price volatility, are PTCT, RTRX, NEU, SPPI, and XXII.
  • SRPT's SEC filings can be seen here. And to visit Sarepta Therapeutics Inc's official web site, go to
SRPT Daily Price Range
SRPT 52-Week Price Range

SRPT Stock Price Chart More Charts

SRPT Price/Volume Stats

Current price $98.04
Prev. close $97.90
Day low $96.54
Day high $99.17
50-day MA $86.36
200-day MA $116.60
52-week high $158.80
52-week low $72.05
Volume 1,132,400
Avg. volume 1,372,598
Dividend yield N/A
Market Cap 7.31B

Sarepta Therapeutics, Inc. (SRPT) Company Bio

Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.

SRPT Latest News Stream

Event/Time News Detail
Loading, please wait...

SRPT Latest Social Stream

Loading social stream, please wait...

View Full SRPT Social Stream

SRPT Price Returns

1-mo 13.18%
3-mo 3.12%
6-mo -18.87%
1-year -16.33%
3-year 153.07%
5-year 523.27%
YTD -10.16%
2018 96.14%
2017 102.84%
2016 -28.90%
2015 166.62%
2014 -28.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6405 seconds.